Episoder
-
Welcome back to the third episode of ESCAP on air.
At ESCAP in Copenhagen 2023, we invited two leading researchers in functional disorders, Judith Rosmalen and Karen Kallesøe, for a conversation about their area of expertise. Judith is a professor in psychosomatic illnesses at the University of Groningen, and Karen is a doctor working in the functional team and research section at the Department of Child and Adolescent Psychiatry in Aarhus.
The interview is divided into two chapters. In the first, we hear our guests talk about functional disorders in general, and in the second, they delve deeper into the challenges of researching functional disorders, as well as the challenges that lie ahead on the horizon.
We recorded this conversation during ESCAP 2023 in Copenhagen and to keep up to date with next year's congress news in Strasbourg 2025, read more about the upcoming congress right here and please subscribe to our newsletter right here.
Hope you enjoy the show.
-
Welcome back to the third episode of ESCAP on air.
At ESCAP in Copenhagen 2023, we invited two leading researchers in functional disorders, Judith Rosmalen and Karen Kallesøe, for a conversation about their area of expertise. Judith is a professor in psychosomatic illnesses at the University of Groningen, and Karen is a doctor working in the functional team and research section at the Department of Child and Adolescent Psychiatry in Aarhus.
The interview is divided into two chapters. In the first, we hear our guests talk about functional disorders in general, and in the second, they delve deeper into the challenges of researching functional disorders, as well as the challenges that lie ahead on the horizon.
We recorded this conversation during ESCAP 2023 in Copenhagen and to keep up to date with next year's congress news in Strasbourg 2025, read more about the upcoming congress right here and please subscribe to our newsletter right here.
Hope you enjoy the show.
-
Manglende episoder?
-
Welcome to the second episode of "ESCAP on air".
Both of our guests are professors and experts in the field of Schizophrenia. For this episode we interviewed Professor Christoph Correll and Professor Anne Katrine Pagsberg about the current leading hypetheses explaining schizophrenia as well as the frontiers of treatment. For the first time in several decades, we are getting close to a pharmaceutical alternative to postsynaptic dopamin blockade and we are introduced to these new pharmaceuticals.
Professor Christoph Correll is affiliated with Charité University in Berlin and is among the top 1% most cited researchers in psychiatry worldwide across various fields. Professor Anne Katrine Pagsberg works at the University of Copenhagen and is particularly known for her work in researching and implementing treatments for young people with first-episode psychosis through the OPUS program.
We recorded this conversation during ESCAP 2023 in Copenhagen and to keep up to date with next year's congress news in Strasbourg 2025, read more about the upcoming congress right here and please subscribe to our newsletter right here.The conversation is split into three chapters to make it easy for you to take a break halfway and pick it up again, when it suits you.
-
Welcome to the second episode of "ESCAP on air".
Both of our guests are professors and experts in the field of Schizophrenia. For this episode we interviewed Professor Christoph Correll and Professor Anne Katrine Pagsberg about the current leading hypetheses explaining schizophrenia as well as the frontiers of treatment. For the first time in several decades, we are getting close to a pharmaceutical alternative to postsynaptic dopamin blockade and we are introduced to these new pharmaceuticals.
Professor Christoph Correll is affiliated with Charité University in Berlin and is among the top 1% most cited researchers in psychiatry worldwide across various fields. Professor Anne Katrine Pagsberg works at the University of Copenhagen and is particularly known for her work in researching and implementing treatments for young people with first-episode psychosis through the OPUS program.
We recorded this conversation during ESCAP 2023 in Copenhagen and to keep up to date with next year's congress news in Strasbourg 2025, read more about the upcoming congress right here and please subscribe to our newsletter right here.The conversation is split into three chapters to make it easy for you to take a break halfway and pick it up again, when it suits you.
-
Welcome to the second episode of "ESCAP on air".
Both of our guests are professors and experts in the field of Schizophrenia. For this episode we interviewed Professor Christoph Correll and Professor Anne Katrine Pagsberg about the current leading hypetheses explaining schizophrenia as well as the frontiers of treatment. For the first time in several decades, we are getting close to a pharmaceutical alternative to postsynaptic dopamin blockade and we are introduced to these new pharmaceuticals.
Professor Christoph Correll is affiliated with Charité University in Berlin and is among the top 1% most cited researchers in psychiatry worldwide across various fields. Professor Anne Katrine Pagsberg works at the University of Copenhagen and is particularly known for her work in researching and implementing treatments for young people with first-episode psychosis through the OPUS program.
We recorded this conversation during ESCAP 2023 in Copenhagen and to keep up to date with next year's congress news in Strasbourg 2025, read more about the upcoming congress right here and please subscribe to our newsletter right here.The conversation is split into three chapters to make it easy for you to take a break halfway and pick it up again, when it suits you.
-
In the first episode in this new podcast from the European Society for Child and Adolescent Psychiatry, "ESCAP on Air," the focus is on mental health at the population level, early interventions and collaboration in research with policy makers. We interview Tamsin Ford, a Professor of Child and Adolescent Psychiatry at the University of Cambridge, and Anna Sofie Kjærgaard Hansen, a specialist and PhD at Aalborg University Hospital. Ford discusses her research on school-based interventions and the importance of involving policymakers, while Hansen shares her insights on service use in psychiatry.We recorded this conversation during ESCAP 2023 in Copenhagen and to keep up to date with next year's congress news in Strasbourg 2025, read more about the upcoming congress right here and please subscribe to our newsletter right here.The conversation is split into two chapters to make it easy for you to take a break halfway and pick it up again, when it suits you.Keywords: child and adolescent psychiatry, mental health, research, interventions, school settings, policymakers, epidemiological research, risk factors, prevalence, education system, health services, organization, evidence-based interventions, ADHD, neurodevelopmental disorders, early assessment, diagnosis, policymakers, collaboration, mental health outcomes.
-
In the first episode in this new podcast from the European Society for Child and Adolescent Psychiatry, "ESCAP on Air," the focus is on mental health at the population level, early interventions and collaboration in research with policy makers. We interview Tamsin Ford, a Professor of Child and Adolescent Psychiatry at the University of Cambridge, and Anna Sofie Kjærgaard Hansen, a specialist and PhD at Aalborg University Hospital. Ford discusses her research on school-based interventions and the importance of involving policymakers, while Hansen shares her insights on service use in psychiatry.We recorded this conversation during ESCAP 2023 in Copenhagen and to keep up to date with next year's congress news in Strasbourg 2025, read more about the upcoming congress right here and please subscribe to our newsletter right here.The conversation is split into two chapters to make it easy for you to take a break halfway and pick it up again, when it suits you.Keywords: child and adolescent psychiatry, mental health, research, interventions, school settings, policymakers, epidemiological research, risk factors, prevalence, education system, health services, organization, evidence-based interventions, ADHD, neurodevelopmental disorders, early assessment, diagnosis, policymakers, collaboration, mental health outcomes.
